Health ❯ Clinical Trials ❯ Drug Development

Regulatory Approval

FDA Process FDA Processes Anvisa FDA Applications FDA Agência Nacional de Vigilância Sanitária

FDA Approves Filspari to Reduce Proteinuria in FSGS Patients Without Nephrotic Syndrome

The decision is based on a 108-week study where the drug beat irbesartan, giving a new option for a rare kidney disease.

Novo Nordisk Files for 7.2 mg Wegovy Dose After Stronger Weight-Loss Results

Adaptimmune Sells Tecelra and Late-Stage Cell Therapies to U.S. WorldMeds for $55M